OCV congratulates Dr. Chris Bostick on receiving the Biocom Life Science Catalyst Award. Chris is a General Partner at OCV Partners with over a decade of interdisciplinary research experience. Chris joined OCV in 2018 and has provided his expertise and leadership to...
OCV Partners (“OCV”) announced today that Dr. Chris Bostick has been promoted to General Partner. Chris joined OCV in 2018 and has provided his expertise and leadership to all of our healthcare investments as well as contributing to many of our non-healthcare...
ByHeart - the only new entrant to the US market to build its infant formula recipe entirely from scratch - achieves all of its clinical trial endpoints in the largest and most comprehensive clinical trial from a new infant formula brand in 25 years, further cementing...
Mobile-first AR solution empowers businesses to transact from anywhere.Expands Bill.com’s footprint to serve international markets. Read Full Story on Businesswire.com SAN JOSE, Calif.--(BUSINESS WIRE)--Bill.com (NYSE:BILL), a leading provider of cloud-based software...
ByHeart is expected to be the first new entrant to the market to build its own manufacturing facility, supply chain and infant formula blend that is based on decades of breast milk research and modern advancements in nutrition science. NEW YORK, June 2,...
Tel Aviv’s Orca AI, a computer vision startup that can be retrofitted to cargo ships and improve navigation and collision avoidance, has raised $13 million in a Series A funding, taking its total raised to over $15.5 million. While most cargo ships carry security...
SOMERVILLE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally...
CAMBRIDGE, Mass., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by...
Company Successfully Surpasses 1,000th Implantation Milestone for its Strong and Bio-integrative OSSIOfiber® Technology WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., an orthopedic fixation technology company, today announced that its OSSIOfiber® Compression Screw...
LOS ANGELES–(BUSINESS WIRE)–Social Native, a marketplace technology company that empowers marketers to source and optimize visual content to improve brand awareness and performance, announced today the acquisition of Olapic, a leading user-generated, influencer, and...
Proceeds to support the advancement of lead candidate through the final stages of clinical development for recurrent C. difficile infection, and the advancement into the clinic of programs for autism spectrum disorder and chronic hepatitis B.Somerville, MA, September...
Experiencing rapid customer growth, the industry’s leading provider of breach-and-attack simulation will use the funding to accelerate the development of new product capabilities and services, expand strategic partnerships and grow its channel relationships with major...
Lead Investors Include Polaris Partners, D1 Capital Partners, and OCV Partners in the Over-Subscribed Round; Former Pfizer Baby Nutrition Leader, as well as Former CEO of J2 Global (What to Expect, BabyCenter and Everyday Health) Join the ByHeart Board of DirectorsNEW...
Complete Offering of Implant Sizes and Shapes Provides Surgeons and their Patients an Intelligent Bone Regeneration Alternative to Metal FixationWOBURN, Mass — OSSIO, Inc., an orthopedic fixation company, today announced that its OSSIOfiber® Hammertoe Fixation System...
– 206 patients randomized at 51 centers in a multinational, placebo-controlled trial– Topline data expected at the end of Q2 2020Somerville, MA (January 8, 2020) — Finch Therapeutics Group, Inc. (“Finch”), a clinical-stage microbiome therapeutics company, announced...
Somerville, MA (August 22, 2019) — Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced today the completion of a $53 million Series C financing. The financing comes from new investors including OCV Partners, Susquehanna...
Funding led by Elizabeth Street Ventures, Maywic Select Investment, and OCV PartnersNew York, NY (August 14, 2019) — Founders of Museum of Ice Cream, Maryellis Bunn and Manish Vora, launch Figure8, an experience-first development company. Figure8, now parent company...
Proceeds to Be Used for US Commercialization and Operational ExpansionWOBURN, MA., March 11, 2019 — OSSIO, an orthopedic fixation company, today announced the closing of $22 million in equity financings led by OCV Partners, a Los Angeles based venture capital firm,...
With our decades of company building experience, we look to create asymmetric advantages when backing winning teams.
